April 21 (Reuters) - Walgreens Boots Alliance WBA.O and its subsidiaries have agreed to pay $300 million to settle U.S. allegations that the pharmacy chain illegally filled millions of invalid prescriptions for opioids and other controlled substances, the U.S. Justice Department said on Monday.
Walgreens will also owe the United States an additional $50 million if the company is sold, merged, or transferred prior to fiscal year 2032, the Justice Department said in a statement.
(Reporting by Ismail Shakil in Ottawa; Editing by Doina Chiacu)
((ismail.shakil@tr.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.